Cubist Systematic Strategies, LLC C4 Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 109,825 shares of CCCC stock, worth $285,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,825

Previous 103,026 6.6%

Holding current value

$285,545

Previous $587,000 32.71%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.6 - $7.0 $24,476 - $47,593	6,799 Added 6.6%	109,825 $395,000
Q3 2024 Nov 14, 2024	SELL	$4.43 - $7.38 $2.03 Million - $3.38 Million	-457,933 Reduced 81.63%	103,026 $587,000
Q2 2024 Aug 14, 2024	SELL	$4.05 - $8.1 $825,807 - $1.65 Million	-203,903 Reduced 26.66%	560,959 $2.59 Million
Q1 2024 May 15, 2024	BUY	$5.3 - $11.0 $2.4 Million - $4.99 Million	453,485 Added 145.64%	764,862 $6.25 Million
Q4 2023 Feb 14, 2024	BUY	$1.18 - $6.03 $287,011 - $1.47 Million	243,230 Added 356.92%	311,377 $1.76 Million
Q3 2023 Nov 14, 2023	SELL	$1.81 - $3.89 $320,469 - $688,743	-177,055 Reduced 72.21%	68,147 $126,000
Q2 2023 Aug 14, 2023	BUY	$2.75 - $3.77 $634,265 - $869,520	230,642 Added 1584.08%	245,202 $674,000
Q1 2023 May 15, 2023	SELL	$3.1 - $9.02 $94,674 - $275,470	-30,540 Reduced 67.72%	14,560 $45,000
Q4 2022 Feb 14, 2023	SELL	$5.42 - $10.24 $221,179 - $417,873	-40,808 Reduced 47.5%	45,100 $266,000
Q3 2022 Nov 14, 2022	SELL	$8.03 - $12.77 $283,539 - $450,908	-35,310 Reduced 29.13%	85,908 $753,000
Q2 2022 Aug 15, 2022	BUY	$5.06 - $26.46 $415,901 - $2.17 Million	82,194 Added 210.62%	121,218 $914,000
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $100,489 - $167,047	5,027 Added 14.79%	39,024 $947,000
Q4 2021 Feb 14, 2022	SELL	$29.39 - $46.86 $97,075 - $154,778	-3,303 Reduced 8.86%	33,997 $1.1 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $989,930 - $1.39 Million	27,567 Added 283.23%	37,300 $1.67 Million
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $295,785 - $410,537	9,733 New	9,733 $368,000
Q1 2021 May 17, 2021	SELL	$31.96 - $46.5 $639,008 - $929,721	-19,994 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $455,863 - $740,777	19,994 New	19,994 $662,000

Others Institutions Holding CCCC

# of Institutions

126

Shares Held

63M

Call Options Held

651K

Put Options Held

115K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $127M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC C4 Therapeutics, Inc. Transaction History